nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—leg—osteoarthritis	0.0322	0.251	CbGeAlD
Arsenic trioxide—AKT1—forelimb—osteoarthritis	0.032	0.25	CbGeAlD
Arsenic trioxide—AKT1—hindlimb—osteoarthritis	0.0288	0.224	CbGeAlD
Arsenic trioxide—CCND1—tendon—osteoarthritis	0.00688	0.0537	CbGeAlD
Arsenic trioxide—TXNRD1—tendon—osteoarthritis	0.0054	0.0421	CbGeAlD
Arsenic trioxide—MAPK3—tendon—osteoarthritis	0.00513	0.0401	CbGeAlD
Arsenic trioxide—AKT1—tendon—osteoarthritis	0.00484	0.0378	CbGeAlD
Arsenic trioxide—JUN—tendon—osteoarthritis	0.00421	0.0329	CbGeAlD
Arsenic trioxide—IKBKB—tendon—osteoarthritis	0.00419	0.0327	CbGeAlD
Arsenic trioxide—ABCC2—tendon—osteoarthritis	0.00229	0.0179	CbGeAlD
Arsenic trioxide—CYP1B1—tendon—osteoarthritis	0.00225	0.0175	CbGeAlD
Arsenic trioxide—AKT1—Downstream signal transduction—IL6—osteoarthritis	0.000149	0.000171	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000149	0.000171	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000149	0.00017	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR—IL6—osteoarthritis	0.000148	0.00017	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1RN—osteoarthritis	0.000148	0.00017	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	0.000148	0.00017	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB2—IL6—osteoarthritis	0.000147	0.000169	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—COL9A1—osteoarthritis	0.000147	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—COL9A2—osteoarthritis	0.000147	0.000169	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CRP—osteoarthritis	0.000147	0.000168	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 signaling—IL6—osteoarthritis	0.000147	0.000168	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000146	0.000168	CbGpPWpGaD
Arsenic trioxide—IKBKB—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000146	0.000168	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HSPA5—osteoarthritis	0.000146	0.000168	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—FN1—osteoarthritis	0.000146	0.000167	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—IL6—osteoarthritis	0.000144	0.000166	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.000144	0.000165	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—IL6—osteoarthritis	0.000144	0.000165	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—IL6—osteoarthritis	0.000144	0.000165	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000144	0.000165	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—IL6—osteoarthritis	0.000143	0.000164	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000143	0.000164	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—COL9A1—osteoarthritis	0.000143	0.000164	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CRP—osteoarthritis	0.000142	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—IL6—osteoarthritis	0.000142	0.000163	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1RN—osteoarthritis	0.000142	0.000163	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—FMOD—osteoarthritis	0.000142	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HSPA5—osteoarthritis	0.000142	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000142	0.000162	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—COL9A2—osteoarthritis	0.00014	0.000161	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—FN1—osteoarthritis	0.000139	0.000159	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—IL6—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—IL6—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR in disease—IL6—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—SMAD3—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1RN—osteoarthritis	0.000138	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—IL6—osteoarthritis	0.000137	0.000158	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR—IL6—osteoarthritis	0.000137	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—IL6—osteoarthritis	0.000137	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—IL6—osteoarthritis	0.000136	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—COL9A1—osteoarthritis	0.000136	0.000156	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000136	0.000156	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000136	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CRP—osteoarthritis	0.000136	0.000155	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—IL6—osteoarthritis	0.000135	0.000155	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by PDGF—IL6—osteoarthritis	0.000135	0.000155	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HSPA5—osteoarthritis	0.000135	0.000155	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—COL9A2—osteoarthritis	0.000134	0.000154	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—IL6—osteoarthritis	0.000134	0.000154	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—IL6—osteoarthritis	0.000134	0.000154	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000134	0.000154	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000133	0.000153	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—MMP9—osteoarthritis	0.000133	0.000152	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—IL6—osteoarthritis	0.000133	0.000152	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GSTO1—osteoarthritis	0.000132	0.000152	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—IGF1—osteoarthritis	0.000132	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000132	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1RN—osteoarthritis	0.000131	0.00015	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—IL6—osteoarthritis	0.000131	0.00015	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—MMP2—osteoarthritis	0.00013	0.000149	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—COL9A1—osteoarthritis	0.00013	0.000149	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—IL6—osteoarthritis	0.00013	0.000149	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CRP—osteoarthritis	0.00013	0.000149	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—PTGS2—osteoarthritis	0.000129	0.000148	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HSPA5—osteoarthritis	0.000129	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—IL6—osteoarthritis	0.000129	0.000148	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—BGN—osteoarthritis	0.000128	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—IGF1—osteoarthritis	0.000128	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—IL6—osteoarthritis	0.000127	0.000146	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—IL6—osteoarthritis	0.000127	0.000146	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000127	0.000146	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—MMP9—osteoarthritis	0.000126	0.000145	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—IL6—osteoarthritis	0.000126	0.000145	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MMP2—osteoarthritis	0.000126	0.000145	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1RN—osteoarthritis	0.000126	0.000144	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.000125	0.000144	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—IL6—osteoarthritis	0.000125	0.000143	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—IL6—osteoarthritis	0.000122	0.00014	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000122	0.00014	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000122	0.00014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—IGF1—osteoarthritis	0.000122	0.00014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP2—osteoarthritis	0.00012	0.000138	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000119	0.000136	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—MMP3—osteoarthritis	0.000118	0.000136	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—LEP—osteoarthritis	0.000118	0.000135	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000118	0.000135	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGES—osteoarthritis	0.000116	0.000133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—MMP3—osteoarthritis	0.000115	0.000132	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000115	0.000131	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—FMOD—osteoarthritis	0.000113	0.00013	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000113	0.000129	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ESR1—osteoarthritis	0.000113	0.000129	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FN1—osteoarthritis	0.000111	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—MMP3—osteoarthritis	0.000109	0.000125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000109	0.000125	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1A—osteoarthritis	0.000107	0.000122	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—BMP2—osteoarthritis	0.000105	0.00012	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—IL6—osteoarthritis	0.000104	0.00012	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1A—osteoarthritis	0.000102	0.000117	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—BMP2—osteoarthritis	0.000101	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1A—osteoarthritis	9.92e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—BMP2—osteoarthritis	9.79e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—MMP9—osteoarthritis	9.78e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	9.75e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IGF1—osteoarthritis	9.74e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—SMAD3—osteoarthritis	9.74e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—IL6—osteoarthritis	9.73e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MMP9—osteoarthritis	9.49e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—SMAD3—osteoarthritis	9.45e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1A—osteoarthritis	9.44e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—IL6—osteoarthritis	9.41e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—BMP2—osteoarthritis	9.31e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—IL6—osteoarthritis	9.28e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—IL6—osteoarthritis	9.25e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGES—osteoarthritis	9.24e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—IL6—osteoarthritis	9.12e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SMAD3—osteoarthritis	9.04e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1A—osteoarthritis	9.03e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP9—osteoarthritis	9.03e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—BMP2—osteoarthritis	8.91e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CRP—osteoarthritis	8.9e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—IL6—osteoarthritis	8.83e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SMAD3—osteoarthritis	8.77e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—IL6—osteoarthritis	8.68e-05	9.96e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CRP—osteoarthritis	8.55e-05	9.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—IL6—osteoarthritis	8.45e-05	9.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SMAD3—osteoarthritis	8.34e-05	9.57e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—IL6—osteoarthritis	8.31e-05	9.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CRP—osteoarthritis	8.3e-05	9.52e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	8.28e-05	9.49e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—IL6—osteoarthritis	8.26e-05	9.47e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GSTO1—osteoarthritis	8.15e-05	9.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TGFB1—osteoarthritis	8.06e-05	9.25e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—ESR1—osteoarthritis	7.95e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TGFB1—osteoarthritis	7.91e-05	9.07e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—BGN—osteoarthritis	7.9e-05	9.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CRP—osteoarthritis	7.89e-05	9.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—IL6—osteoarthritis	7.86e-05	9.01e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CXCL8—osteoarthritis	7.83e-05	8.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TGFB1—osteoarthritis	7.82e-05	8.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—ESR1—osteoarthritis	7.71e-05	8.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TGFB1—osteoarthritis	7.67e-05	8.8e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CRP—osteoarthritis	7.55e-05	8.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—osteoarthritis	7.53e-05	8.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TGFB1—osteoarthritis	7.44e-05	8.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—osteoarthritis	7.3e-05	8.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TGFB1—osteoarthritis	7.3e-05	8.37e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP3—osteoarthritis	7.28e-05	8.35e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP9—osteoarthritis	7.08e-05	8.13e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.05e-05	8.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP3—osteoarthritis	7e-05	8.02e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—FMOD—osteoarthritis	6.99e-05	8.01e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—osteoarthritis	6.95e-05	7.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP3—osteoarthritis	6.79e-05	7.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—CXCL8—osteoarthritis	6.7e-05	7.69e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SMAD3—osteoarthritis	6.59e-05	7.56e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	6.58e-05	7.55e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GSTO1—osteoarthritis	6.51e-05	7.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP3—osteoarthritis	6.46e-05	7.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SMAD3—osteoarthritis	6.33e-05	7.26e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—BGN—osteoarthritis	6.31e-05	7.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP3—osteoarthritis	6.18e-05	7.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SMAD3—osteoarthritis	6.14e-05	7.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCL8—osteoarthritis	6.09e-05	6.98e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—IL6—osteoarthritis	6.07e-05	6.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCL8—osteoarthritis	5.9e-05	6.77e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—IL6—osteoarthritis	5.89e-05	6.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SMAD3—osteoarthritis	5.84e-05	6.7e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TGFB1—osteoarthritis	5.84e-05	6.7e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGES—osteoarthritis	5.69e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LEP—osteoarthritis	5.63e-05	6.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL8—osteoarthritis	5.62e-05	6.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—IL6—osteoarthritis	5.61e-05	6.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SMAD3—osteoarthritis	5.59e-05	6.41e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—IL6—osteoarthritis	5.58e-05	6.4e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL1B—osteoarthritis	5.55e-05	6.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LEP—osteoarthritis	5.41e-05	6.21e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ESR1—osteoarthritis	5.38e-05	6.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—IL6—osteoarthritis	5.36e-05	6.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL1B—osteoarthritis	5.34e-05	6.12e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FN1—osteoarthritis	5.31e-05	6.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PTGS2—osteoarthritis	5.3e-05	6.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LEP—osteoarthritis	5.25e-05	6.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—IL6—osteoarthritis	5.2e-05	5.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL1B—osteoarthritis	5.18e-05	5.94e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ESR1—osteoarthritis	5.17e-05	5.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PTGS2—osteoarthritis	5.14e-05	5.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FN1—osteoarthritis	5.1e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	5.1e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ESR1—osteoarthritis	5.01e-05	5.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LEP—osteoarthritis	4.99e-05	5.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—IL6—osteoarthritis	4.95e-05	5.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FN1—osteoarthritis	4.95e-05	5.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL1B—osteoarthritis	4.92e-05	5.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PTGS2—osteoarthritis	4.89e-05	5.61e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LEP—osteoarthritis	4.78e-05	5.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ESR1—osteoarthritis	4.77e-05	5.47e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—IL6—osteoarthritis	4.74e-05	5.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL1B—osteoarthritis	4.71e-05	5.4e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FN1—osteoarthritis	4.71e-05	5.4e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IGF1—osteoarthritis	4.65e-05	5.34e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ESR1—osteoarthritis	4.56e-05	5.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FN1—osteoarthritis	4.51e-05	5.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IGF1—osteoarthritis	4.47e-05	5.13e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTGS2—osteoarthritis	4.43e-05	5.09e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—IL6—osteoarthritis	4.4e-05	5.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IGF1—osteoarthritis	4.34e-05	4.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IGF1—osteoarthritis	4.13e-05	4.73e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GSTO1—osteoarthritis	4.01e-05	4.6e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IGF1—osteoarthritis	3.95e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—BGN—osteoarthritis	3.89e-05	4.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—osteoarthritis	3.83e-05	4.39e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL8—osteoarthritis	3.74e-05	4.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—osteoarthritis	3.71e-05	4.26e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTGS2—osteoarthritis	3.69e-05	4.23e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL8—osteoarthritis	3.6e-05	4.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—osteoarthritis	3.53e-05	4.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL8—osteoarthritis	3.49e-05	4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—IL6—osteoarthritis	3.42e-05	3.92e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—osteoarthritis	3.39e-05	3.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL8—osteoarthritis	3.32e-05	3.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—IL6—osteoarthritis	3.32e-05	3.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—osteoarthritis	3.25e-05	3.73e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—IL6—osteoarthritis	3.25e-05	3.73e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL8—osteoarthritis	3.18e-05	3.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—IL6—osteoarthritis	3.16e-05	3.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—osteoarthritis	3.16e-05	3.62e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—IL6—osteoarthritis	3.12e-05	3.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—IL6—osteoarthritis	3.03e-05	3.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—osteoarthritis	3e-05	3.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—IL6—osteoarthritis	2.88e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—IL6—osteoarthritis	2.88e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—osteoarthritis	2.87e-05	3.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—IL6—osteoarthritis	2.8e-05	3.21e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—osteoarthritis	2.79e-05	3.2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—IL6—osteoarthritis	2.76e-05	3.16e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—osteoarthritis	2.68e-05	3.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—IL6—osteoarthritis	2.66e-05	3.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—osteoarthritis	2.6e-05	2.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—osteoarthritis	2.47e-05	2.84e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—osteoarthritis	2.37e-05	2.72e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTGS2—osteoarthritis	2.27e-05	2.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—IL6—osteoarthritis	2.1e-05	2.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—IL6—osteoarthritis	2.02e-05	2.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—IL6—osteoarthritis	1.96e-05	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—IL6—osteoarthritis	1.86e-05	2.14e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTGS2—osteoarthritis	1.81e-05	2.08e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—IL6—osteoarthritis	1.78e-05	2.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTGS2—osteoarthritis	1.12e-05	1.28e-05	CbGpPWpGaD
